ARTICLES BY ALETHEA WIELAND
-
Regulatory Science & Clinical Research: Where Do We Stand (And Where Are We Going)?7/14/2020
This article will share some thoughts on the current state of regulatory science, by reflecting back on two prominent meetings — the inaugural UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) Summit and the Clinical Trials Transformation Initiative (CTTI) Virtual Meetings for Stakeholder Engagement on ICH E6.
-
What's Really Behind The CRA Shortage In Clinical Trials? A Root Cause Analysis3/18/2020
The #1 and #2 complaints I hear consistently from peers and partners in life sciences companies are the inability to hold third-party partners and CROs accountable for quality performance and to have a consistent experienced team over the life of their clinical trial. The two are inextricably linked.